Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels

被引:20
作者
Koks, S
Vasar, E
Soosaar, A
Lang, A
Volke, V
Voikar, V
Bourin, M
Mannisto, PT
机构
[1] Tartu State Univ, Dept Physiol, EE-2400 Tartu, Estonia
[2] Univ Nantes, Pharmacol Lab, F-44035 Nantes, France
[3] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
关键词
elevated plus-maze; exploratory activity; selection of rats; neurotransmitter receptors; blood hormone levels;
D O I
10.1016/S0924-977X(97)00034-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Forty-five male Wistar rats were selected according to their behavior in the elevated plus-maze. They were separated as follows: animals with low exploratory activity ('anxious'), an 'intermediate' group and animals having high exploratory activity ('non-anxious'). Various receptor binding studies and hormonal assays were also performed in these selected rats. The affinity of 5-hydroxytryptamine 5-HT(2A) receptors in the frontal cortex was lower in the 'anxious' rats compared to home-cage controls and 'non-anxious' animals. Moreover, the number of cholecystokinin (CCK) receptors in the hippocampus was significantly elevated in the 'anxious' group compared to home-cage control animals. The blood levels of growth hormone (GH) were significantly lower in the 'non-anxious' rats compared to 'anxious' counterparts. In conclusion, it seems likely that the decreased exploratory activity of rats is related to the increased 5-hydroxytryptamine (5-HT) and CCK mediated neurotransmission in the brain. The different serum levels of GH in the selected rats probably reflect alterations in the activity of 5-HT and CCK. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:289 / 294
页数:6
相关论文
共 36 条
[1]   INCREASED 5-HT RELEASE MEDIATES THE ANXIOGENIC RESPONSE DURING BENZODIAZEPINE WITHDRAWAL - A REVIEW OF SUPPORTING NEUROCHEMICAL AND BEHAVIORAL EVIDENCE [J].
ANDREWS, N ;
FILE, SE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :21-25
[2]   5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS [J].
BARRETT, JE ;
VANOVER, KE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :1-12
[3]   PD135158, A CCK-B ANTAGONIST, REDUCES STATE, BUT NOT TRAIT ANXIETY IN MICE [J].
BELZUNG, C ;
PINEAU, N ;
BEUZEN, A ;
MISSLIN, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (02) :433-436
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   BENZODIAZEPINES ANTAGONIZE CHOLECYSTOKININ-INDUCED ACTIVATION OF RAT HIPPOCAMPAL-NEURONS [J].
BRADWEJN, J ;
DEMONTIGNY, C .
NATURE, 1984, 312 (5992) :363-364
[6]   SPECIFIC BENZODIAZEPINE RECEPTORS IN RAT-BRAIN CHARACTERIZED BY HIGH-AFFINITY [DIAZEPAM-H-3] BINDING - (AFFINITY BINDING DIAZEPAM ANXIOLYTIC ACTIVITY BRAIN MEMBRANES REGIONAL DISTRIBUTION) [J].
BRAESTRUP, C ;
SQUIRES, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3805-3809
[7]   SEROTONIN FUNCTION IN ANXIETY .2. EFFECTS OF THE SEROTONIN AGONIST MCPP IN PANIC DISORDER PATIENTS AND HEALTHY-SUBJECTS [J].
CHARNEY, DS ;
WOODS, SW ;
GOODMAN, WK ;
HENINGER, GR .
PSYCHOPHARMACOLOGY, 1987, 92 (01) :14-24
[8]   BIOLOGICAL ACTIONS OF CHOLECYSTOKININ [J].
CRAWLEY, JN ;
CORWIN, RL .
PEPTIDES, 1994, 15 (04) :731-755
[9]   SOCIAL-INTERACTION AND ELEVATED PLUS-MAZE TESTS - CHANGES IN RELEASE AND UPTAKE OF 5-HT AND GABA [J].
FILE, SE ;
ZANGROSSI, H ;
ANDREWS, N .
NEUROPHARMACOLOGY, 1993, 32 (03) :217-221
[10]   VULNERABILITY TO STRESS ULCEROGENESIS IN RATS DIFFERING IN ANXIETY - A DOPAMINERGIC CORRELATE [J].
GLAVIN, GB .
JOURNAL OF PHYSIOLOGY-PARIS, 1993, 87 (04) :239-243